4-(3-(4-phenylpiperazin-1-yl)propoxy)-9H-carbazole

ID: ALA4637718

PubChem CID: 156011380

Max Phase: Preclinical

Molecular Formula: C25H27N3O

Molecular Weight: 385.51

Molecule Type: Unknown

Associated Items:

This compound is not in our inventory system

Names and Identifiers

Canonical SMILES:  c1ccc(N2CCN(CCCOc3cccc4[nH]c5ccccc5c34)CC2)cc1

Standard InChI:  InChI=1S/C25H27N3O/c1-2-8-20(9-3-1)28-17-15-27(16-18-28)14-7-19-29-24-13-6-12-23-25(24)21-10-4-5-11-22(21)26-23/h1-6,8-13,26H,7,14-19H2

Standard InChI Key:  AICURCPXKFTXPV-UHFFFAOYSA-N

Molfile:  

 
     RDKit          2D

 29 33  0  0  0  0  0  0  0  0999 V2000
   40.4747  -20.8078    0.0000 C   0  0  0  0  0  0  0  0  0  0  0  0
   40.4747  -19.9823    0.0000 O   0  0  0  0  0  0  0  0  0  0  0  0
   43.3412  -19.9698    0.0000 N   0  0  0  0  0  0  0  0  0  0  0  0
   41.9059  -19.9823    0.0000 C   0  0  0  0  0  0  0  0  0  0  0  0
   41.1883  -19.5674    0.0000 C   0  0  0  0  0  0  0  0  0  0  0  0
   42.6277  -19.5674    0.0000 C   0  0  0  0  0  0  0  0  0  0  0  0
   41.1924  -22.0439    0.0000 C   0  0  0  0  0  0  0  0  0  0  0  0
   41.1924  -21.2185    0.0000 C   0  0  0  0  0  0  0  0  0  0  0  0
   40.4789  -22.4587    0.0000 C   0  0  0  0  0  0  0  0  0  0  0  0
   39.7608  -22.0439    0.0000 C   0  0  0  0  0  0  0  0  0  0  0  0
   39.7654  -21.2185    0.0000 C   0  0  0  0  0  0  0  0  0  0  0  0
   38.9741  -22.2934    0.0000 N   0  0  0  0  0  0  0  0  0  0  0  0
   38.4949  -21.6263    0.0000 C   0  0  0  0  0  0  0  0  0  0  0  0
   38.9831  -20.9626    0.0000 C   0  0  0  0  0  0  0  0  0  0  0  0
   38.6557  -20.2079    0.0000 C   0  0  0  0  0  0  0  0  0  0  0  0
   37.8364  -20.1160    0.0000 C   0  0  0  0  0  0  0  0  0  0  0  0
   37.3455  -20.7804    0.0000 C   0  0  0  0  0  0  0  0  0  0  0  0
   37.6796  -21.5323    0.0000 C   0  0  0  0  0  0  0  0  0  0  0  0
   43.3532  -20.7952    0.0000 C   0  0  0  0  0  0  0  0  0  0  0  0
   44.0506  -19.5447    0.0000 C   0  0  0  0  0  0  0  0  0  0  0  0
   44.7720  -19.9450    0.0000 C   0  0  0  0  0  0  0  0  0  0  0  0
   44.7839  -20.7704    0.0000 N   0  0  0  0  0  0  0  0  0  0  0  0
   44.0745  -21.1955    0.0000 C   0  0  0  0  0  0  0  0  0  0  0  0
   45.5053  -21.1748    0.0000 C   0  0  0  0  0  0  0  0  0  0  0  0
   45.5157  -21.9993    0.0000 C   0  0  0  0  0  0  0  0  0  0  0  0
   46.2363  -22.3995    0.0000 C   0  0  0  0  0  0  0  0  0  0  0  0
   46.9467  -21.9785    0.0000 C   0  0  0  0  0  0  0  0  0  0  0  0
   46.9320  -21.1489    0.0000 C   0  0  0  0  0  0  0  0  0  0  0  0
   46.2110  -20.7483    0.0000 C   0  0  0  0  0  0  0  0  0  0  0  0
  1 11  1  0
  2  1  1  0
  3  6  1  0
  4  5  1  0
  5  2  1  0
  6  4  1  0
  7  9  2  0
  8  1  2  0
  9 10  1  0
  8  7  1  0
 10 11  2  0
 11 14  1  0
 13 12  1  0
 12 10  1  0
 13 14  2  0
 14 15  1  0
 15 16  2  0
 16 17  1  0
 17 18  2  0
 18 13  1  0
  3 19  1  0
  3 20  1  0
 20 21  1  0
 19 23  1  0
 21 22  1  0
 22 23  1  0
 22 24  1  0
 24 25  2  0
 25 26  1  0
 26 27  2  0
 27 28  1  0
 28 29  2  0
 29 24  1  0
M  END

Alternative Forms

  1. Parent:

    ALA4637718

    ---

Associated Targets(Human)

SK-MEL-5 (47095 Activities)
Activity TypeRelationActivity valueUnitsAction TypeJournalPubMed IddoiAssay Aladdin ID
SK-MEL-28 (48833 Activities)
Activity TypeRelationActivity valueUnitsAction TypeJournalPubMed IddoiAssay Aladdin ID
A-375 (9258 Activities)
Activity TypeRelationActivity valueUnitsAction TypeJournalPubMed IddoiAssay Aladdin ID

Molecule Features

Natural Product: NoOral: NoChemical Probe: NoParenteral: No
Molecule Type: UnknownTopical: NoFirst In Class: NoBlack Box: No
Chirality: NoAvailability: NoProdrug: No

Drug Indications

MESH IDMESH Heading EFO IDsEFO TermsMax Phase for IndicationReferences

Mechanisms of Action

Mechanism of ActionAction Typetarget IDTarget NameTarget TypeTarget OrganismBinding Site NameReferences

Calculated Properties

Molecular Weight: 385.51Molecular Weight (Monoisotopic): 385.2154AlogP: 4.91#Rotatable Bonds: 6
Polar Surface Area: 31.50Molecular Species: NEUTRALHBA: 3HBD: 1
#RO5 Violations: HBA (Lipinski): 4HBD (Lipinski): 1#RO5 Violations (Lipinski):
CX Acidic pKa: CX Basic pKa: 8.03CX LogP: 4.75CX LogD: 4.03
Aromatic Rings: 4Heavy Atoms: 29QED Weighted: 0.48Np Likeness Score: -0.83

References

1. Chang Q, Long J, Hu L, Chen Z, Li Q, Hu G..  (2020)  Drug repurposing and rediscovery: Design, synthesis and preliminary biological evaluation of 1-arylamino-3-aryloxypropan-2-ols as anti-melanoma agents.,  28  (9): [PMID:32216987] [10.1016/j.bmc.2020.115404]

Source